Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Liu

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Vaccine|November 27, 2007
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3John D Osborne, Melissa Da Silva, A Michael Frace, et al.
Nature Neuroscience|July 28, 2025
Astrocyte specification in the mouse septum is shaped by both developmental origin and local signalsYajun Xie, Christopher M Reid, Miguel Turrero Garcίa, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
American Journal of Perinatology|October 14, 2022
A Description of the Imaging Innovations for Placental Assessment in Response to Environmental Pollution StudyCarla Janzen, Margarida Y Y Lei, Brian R Lee, et al.
Blood|February 17, 2017
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10Rick Kapur, Michael Kim, Rukhsana Aslam, et al.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
BMJ Open|March 15, 2024
Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)Ranjani Somayaji, David R Luke, Arthur Lau, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Theranostics|November 24, 2021
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopesNadia Benabdallah, William Scheve, Nicholas Dunn, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Vaccine|November 27, 2007
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3John D Osborne, Melissa Da Silva, A Michael Frace, et al.
Nature Neuroscience|July 28, 2025
Astrocyte specification in the mouse septum is shaped by both developmental origin and local signalsYajun Xie, Christopher M Reid, Miguel Turrero Garcίa, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
American Journal of Perinatology|October 14, 2022
A Description of the Imaging Innovations for Placental Assessment in Response to Environmental Pollution StudyCarla Janzen, Margarida Y Y Lei, Brian R Lee, et al.
Blood|February 17, 2017
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10Rick Kapur, Michael Kim, Rukhsana Aslam, et al.
Therapeutic Advances in Chronic Disease|September 9, 2022
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and descriptionMaria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
BMJ Open|March 15, 2024
Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)Ranjani Somayaji, David R Luke, Arthur Lau, et al.
Therapeutic Advances in Chronic Disease|May 20, 2024
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysisAnnemieke M Boot, Gema Ariceta, Signe Sparre Beck-Nielsen, et al.
Theranostics|November 24, 2021
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopesNadia Benabdallah, William Scheve, Nicholas Dunn, et al.
Orphanet Journal of Rare Diseases|September 26, 2023
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical dataGema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M Boot, et al.
Pageof 18